Registered outcomes17

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

1 to 17 of 17

List	Outcome	Time frame	Description
Primary	Weight	12 weeks	in Kg, at least 5% weight loss
Primary	Body mass index	12 weeks	Kg per meter square
Primary	Waist circumference	12 weeks	Centimeter
Primary	Hip circumference	12 weeks	Centimeter
Primary	Blood pressure	12 weeks	mm of Hg
Primary	Acanthosis nigricans	12 weeks	Present or absent
Primary	Fasting plasma glucose	12 weeks	mmol/L
Primary	Fasting insulin	12 weeks	micro international unit per mL
Primary	Homeostasis model assessment of insulin resistance	12 weeks	Using formula provided by Mathew's et al. (1985)
Primary	Total cholesterol	12 weeks	mg/dL
Primary	HDL-cholesterol	12 weeks	mg/dL
Primary	LDL-cholesterol	12 weeks	mg/dL
Primary	Triglyceride	12 weeks	mg/dL
Secondary	Total testosterone	12 weeks	ng/dL
Secondary	Sex hormone binding globulin	12 weeks	nmol/L
Secondary	Free androgen index	12 weeks	in %
Secondary	Alanine amino transferase	12 weeks	U/L

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT06896981/registered